Compare Braze Inc (BRZE) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Braze Inc vs Cytokinetics Inc — how do they compare? Braze Inc trades at $28.04 (market cap $3.18B), while Cytokinetics Inc trades at $76.67 (market cap $10.63B). The key difference: Cytokinetics Inc is far larger — about 3.3× Braze Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Braze Inc nearer its low. Which is the better fit depends on your goals.
| BRZE | CYTK | |
|---|---|---|
Market Cap | $3.18B | $10.63B |
Sector | Technology | Technology |
52-Week High | $36.19 | $87.26 |
52-Week Low | $15.79 | $34.31 |
Enterprise Value | $2.87B | $10.74B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Braze Inc
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
